Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive Effects of Sitagliptin on Endothelial Dysfunction Induced by Forearm Ischemia-Reperfusion Injury
NCT02406950Phase 3Unknown
- Sponsor
- Kyung Hee University Medical Center
- Start
- Feb 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in ischemia-reperfusion injury (IRI), sponsored by Kyung Hee University Medical Center. Status: unknown.
02
Drugs
sitagliptin
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT02406950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02406950.